Starts & Stops: CardioFocus Studies HeartLight X3 In Persistent AF; IntraLink Spine Launches Trial Of Low-Back Device In Australia

 
• By Reed Miller

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from March 4 through March 17, including trial announcements from CardioFocus, Innovative Cardiovascular Solutions, IntraLink-Spine, Geneveve, Acutus, and Stereotaxis.

• Source: shutterstock.com

[Editors Note: Starts & Stops is Medtech Insight’s regular review of important medical device trial announcements as tracked by Informa’s MedDeviceTracker. Click here to request a demonstration. For an archive of previous Starts & Stops and Results Recap, MTI's regular updates on trial outcomes, visit the Tracking Trials page.]

A 60-patient clinical study evaluating CardioFocus’ HeartLight X3 laser balloon ablation catheter for treatment of persistent atrial fibrillation has...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D